Infection Surveillance Solutions Market Outlook:
Infection Surveillance Solutions Market size was over USD 832.2 million in 2025 and is poised to exceed USD 3 billion by 2035, growing at over 13.7% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of infection surveillance solutions is estimated at USD 934.81 million.
The primary growth driver for the infection surveillance solutions market is the increasing prevalence of infectious diseases and the rising awareness of infection control in healthcare settings. This includes the need for effective monitoring and tracking of infections to improve patient outcomes, prevent outbreaks, and enhance overall healthcare quality. According to the Department of Biotechnology, Ministry of Science and Technology, Government of India, infectious diseases are among the top ten causes of death in the country, led by diarrheal diseases, neonatal disorders, lower respiratory infections, and tuberculosis.
The infection surveillance solutions market is also expanding due to an increase in hospital-acquired infections (HAIs). According to the World Health Organization (WHO), HAIs impact one out of every ten patients on average. However, in low- and middle-income nations, as well as among high-risk patients in intensive care units, the frequency may be much higher.
